AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45

Authors: ZIETMAN AL
Citation: Al. Zietman, RADIATION-THERAPY OR PROSTATECTOMY - AN OLD CONFLICT REVISITED IN THEPSA ERA - A RADIATION ONCOLOGISTS VIEWPOINT, Seminars in radiation oncology, 8(2), 1998, pp. 81-86

Authors: SHIPLEY WU KAUFMAN DS HENEY NM ALTHAUSEN AF ZIETMAN AL
Citation: Wu. Shipley et al., AN UPDATE OF SELECTIVE BLADDER PRESERVATION BY COMBINED-MODALITY THERAPY FOR INVASIVE BLADDER-CANCER, European urology, 33, 1998, pp. 32-34

Authors: ZIETMAN AL SHIPLEY WU KAUFMAN DS ZEHR EM HENEY NM ALTHAUSEN AF MCGOVERN FJ
Citation: Al. Zietman et al., A PHASE I II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE-DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER-CANCER/, The Journal of urology, 160(5), 1998, pp. 1673-1677

Authors: KANADY KE SHIPLEY WU ZIETMAN AL KAUFMAN DS ALTHAUSEN AF HENEY NM
Citation: Ke. Kanady et al., TREATMENT STRATEGIES USING TRANSURETHRAL SURGERY, CHEMOTHERAPY, AND RADIATION-THERAPY WITH SELECTION THAT SAFELY ALLOWS BLADDER CONSERVATION FOR INVASIVE BLADDER-CANCER, Seminars in surgical oncology, 13(5), 1997, pp. 359-364

Authors: ZIETMAN AL NAKFOOR BM PRINCE EA GERWECK LE
Citation: Al. Zietman et al., THE EFFECT OF ANDROGEN DEPRIVATION AND RADIATION-THERAPY ON AN ANDROGEN SENSITIVE MURINE TUMOR - AN IN-VITRO AND IN-VIVO STUDY, The cancer journal from Scientific American, 3(1), 1997, pp. 31-36

Authors: COIA LR MINSKY BD JOHN M HALLER D HOFFMAN J LANDRY J PISANSKY T WILLET C WILSON JF FOWBLE B HARRIS J KUSKE RR LAGIOS MD MCNEESE M MONSEES B MORROW M RECHT A ROSE CM SHANK BM WHITE JR WINCHESTER D EIFEL P GRIGSBY P LANCIANO R LING C MONTANA G ROMAN LD SCHOEPPEL S STITT J THOMAS GM HANKS GE THOMAS GM KUBAN DA BENSON M CHODAK G LARAMORE GE PEREZ CA ROACH M SANDLER HM SCHER H SCHULTHEISS TE ZIETMAN AL
Citation: Lr. Coia et al., 1996 DECISION TREES AND MANAGEMENT GUIDELINES, Seminars in radiation oncology, 7(2), 1997, pp. 163-181

Authors: ZIETMAN AL SHIPLEY WU
Citation: Al. Zietman et Wu. Shipley, PROGRESS IN THE MANAGEMENT OF T3-4 ADENOCARCINOMA OF THE PROSTATE, European journal of cancer, 33(4), 1997, pp. 555-559

Authors: KACHNIC LA KAUFMAN DS HENEY NM ALTHAUSEN AF GRIFFIN PP ZIETMAN AL SHIPLEY WU
Citation: La. Kachnic et al., BLADDER PRESERVATION BY COMBINED-MODALITY THERAPY FOR INVASIVE BLADDER-CANCER, Journal of clinical oncology, 15(3), 1997, pp. 1022-1029

Authors: POWSNER RA ZIETMAN AL FOSS FM
Citation: Ra. Powsner et al., BONE-MARROW SUPPRESSION AFTER SR-89 THERAPY AND LOCAL RADIATION-THERAPY IN PATIENTS WITH DIFFUSE MARROW INVOLVEMENT, Clinical nuclear medicine, 22(3), 1997, pp. 147-150

Authors: SHIPLEY WU ZIETMAN AL KAUFMAN DS ALTHAUSEN AF HENEY NM
Citation: Wu. Shipley et al., INVASIVE BLADDER-CANCER - TREATMENT STRATEGIES USING TRANSURETHRAL SURGERY, CHEMOTHERAPY AND RADIATION-THERAPY WITH SELECTION FOR BLADDER CONSERVATION, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 937-943

Authors: SHIPLEY WU ZIETMAN AL
Citation: Wu. Shipley et Al. Zietman, BLADDER-CANCER - THE COMBINATION OF CHEMOTHERAPY AND IRRADIATION IN THE TREATMENT OF PATIENTS WITH MUSCLE-INVADING TUMORS, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 118-118

Authors: ZIETMAN AL KAUFMAN DS SHIPLEY WU PARK JJ ALTHAUSEN AF GOMERY P YOUNG HH MCGOVERN FV HENEY NM
Citation: Al. Zietman et al., A PHASE I II TRIAL OF TRANSURETHRAL SURGERY PLUS CISPLATIN AND RADIATION-THERAPY FOLLOWED BY EITHER SELECTIVE BLADDER PRESERVATION OR RADICAL CYSTECTOMY FOR PATIENTS WITH MUSCLE-INVADING BLADDER-CANCER BUT WITHOUT HYDRONEPHROSIS/, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 155-155

Authors: MORRIS AD ZIETMAN AL ALTHAUSEN AF HENEY NM KAUFMAN DS SHIPLEY WU
Citation: Ad. Morris et al., THE VALUE OF EXTERNAL-BEAM RADIATION IN PATHOLOGICAL NODE-POSITIVE PROSTATE-CANCER - A MULTIVARIATE-ANALYSIS, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 217-217

Authors: ZIETMAN AL PRINCE EA NAKFOOR BM PARK JJ
Citation: Al. Zietman et al., ANDROGEN DEPRIVATION AND RADIATION-THERAPY - SEQUENCING STUDIES USINGTHE SHIONOGI IN-VIVO TUMOR SYSTEM, International journal of radiation oncology, biology, physics, 38(5), 1997, pp. 1067-1070

Authors: MORRIS MM DALLOW KC ZIETMAN AL PARK J ALTHAUSEN A HENEY NM SHIPLEY WU
Citation: Mm. Morris et al., ADJUVANT AND SALVAGE IRRADIATION FOLLOWING RADICAL PROSTATECTOMY FOR PROSTATE-CANCER, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 731-736

Authors: COX JD GRIGNON DJ KAPLAN RS PARSONS JT SCHELLHAMMER PF ZAGARS GK ZIETMAN AL SHIPLEY WU
Citation: Jd. Cox et al., CONSENSUS STATEMENT - GUIDELINES FOR PSA FOLLOWING RADIATION-THERAPY, International journal of radiation oncology, biology, physics, 37(5), 1997, pp. 1035-1041

Authors: ZIETMAN AL SHIPLEY WU
Citation: Al. Zietman et Wu. Shipley, ANDROGEN DEPRIVATION AND RADIATION-THERAPY IN PROSTATE-CANCER - THE EVOLVING CASE FOR COMBINATION THERAPY, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 245-246

Authors: ZIETMAN AL PRINCE EA NAKFOOR BM SHIPLEY WU
Citation: Al. Zietman et al., NEOADJUVANT ANDROGEN SUPPRESSION WITH RADIATION IN THE MANAGEMENT OF LOCALLY ADVANCED ADENOCARCINOMA OF THE PROSTATE - EXPERIMENTAL AND CLINICAL-RESULTS, Urology, 49(3A), 1997, pp. 74-83

Authors: HARTFORD AC ZIETMAN AL
Citation: Ac. Hartford et Al. Zietman, PROSTATE-CANCER - WHO IS BEST BENEFITED BY EXTERNAL-BEAM RADIATION-THERAPY, Hematology/oncology clinics of North America, 10(3), 1996, pp. 595

Authors: ZIETMAN AL TIBBS MK DALLOW KC SMITH CT ALTHAUSEN AF ZLOTECKI RA SHIPLEY WU
Citation: Al. Zietman et al., USE OF PSA NADIR TO PREDICT SUBSEQUENT BIOCHEMICAL OUTCOME FOLLOWING EXTERNAL-BEAM RADIATION-THERAPY FOR T1-2 ADENOCARCINOMA OF THE PROSTATE, Radiotherapy and oncology, 40(2), 1996, pp. 159-162

Authors: DOUGLAS RM KAUFMAN DS ZIETMAN AL ALTHAUSEN AF HENEY NM SHIPLEY WU
Citation: Rm. Douglas et al., CONSERVATIVE SURGERY, PATIENT SELECTION, AND CHEMORADIATION AS ORGAN-PRESERVING TREATMENT FOR MUSCLE-INVADING BLADDER-CANCER, Seminars in oncology, 23(5), 1996, pp. 614-620

Authors: EDELSTEIN RA ZIETMAN AL DELASMORENAS A KRANE RJ BABAYAN RK DALLOW KC TRAISH A MORELAND RB
Citation: Ra. Edelstein et al., IMPLICATIONS OF PROSTATE MICROMETASTASES IN PELVIC LYMPH-NODES - AN ARCHIVAL TISSUE STUDY, Urology, 47(3), 1996, pp. 370-375

Authors: ZIETMAN AL DALLOW KC MCMANUS PA HENEY NM SHIPLEY WU
Citation: Al. Zietman et al., TIME TO 2ND PROSTATE-SPECIFIC ANTIGEN FAILURE IS A SURROGATE END-POINT FOR PROSTATE-CANCER DEATH IN A PROSPECTIVE TRIAL OF THERAPY FOR LOCALIZED DISEASE, Urology, 47(2), 1996, pp. 236-239

Authors: ZIETMAN AL COEN JJ FERRY JA SCULLY RE KAUFMAN DS MCGOVERN FG
Citation: Al. Zietman et al., THE MANAGEMENT AND OUTCOME OF STAGE IA(E) NONHODGKINS LYMPHOMA OF THETESTIS, The Journal of urology, 155(3), 1996, pp. 943-946

Authors: COLVETT KT ALTHAUSEN AF BASSIL B HENEY NM MCGOVERN FV YOUNG HH KAUFMAN DS ZIETMAN AL SHIPLEY WU
Citation: Kt. Colvett et al., OPPORTUNITIES WITH COMBINED-MODALITY THERAPY FOR SELECTIVE ORGAN PRESERVATION IN MUSCLE-INVASIVE BLADDER-CANCER, Journal of surgical oncology, 63(3), 1996, pp. 201-208
Risultati: 1-25 | 26-45